Antibody Drug Conjugate (ADC) Drug Market Report

Global and China Antibody Drug Conjugate (ADC) Drug Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 29, 2022
  • PAGES：183
  • REPORT CODE：GMM1504887
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Antibody Drug Conjugate (ADC) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Oxford Bio Therapeutics

    • Sanofi

    • Millennium Pharmaceuticals

    • Genentech

    • Amgen

    • Celldex Therapeutics

    • Immunomedics

    • Bayer HealthCare

    • Mersana Therapeutics

    • ImmunoGen

    • Concortis Bio therapeutics

    • Heidelberg Pharma

    • Seattle Genetics

    • AbbVie Inc

    • Synthon

    • Genmab

    • Novartis

    • Agensys

    • Pfizer

    • Progenics Pharmaceuticals

    • Roche Holding AG

    • Eli Lilly

    • Astellas Pharma/Agensys

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • by Technology

    • Mmunomedics Technology

    • Immunogen Technology

    • Mersana Therapeutics Technology

    • Others

    • by Product Type

    • Kadcyla

    • Adcertis

    Application:

    • Biotechnology Companies

    • Specialized Cancer Centers

    • Biopharmaceutical Companies

    • Academic Research Institutes

    • Hospitals

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Antibody Drug Conjugate (ADC) Drug Industry Overview

      • 1.1.1 Antibody Drug Conjugate (ADC) Drug Market Scope and Market Segments

      • 1.1.2 Antibody Drug Conjugate (ADC) Drug Industry Characteristics

      • 1.1.3 Global and China Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Antibody Drug Conjugate (ADC) Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 by Technology

      • 1.2.2 Mmunomedics Technology

      • 1.2.3 Immunogen Technology

      • 1.2.4 Mersana Therapeutics Technology

      • 1.2.5 Others

      • 1.2.6 by Product Type

      • 1.2.7 Kadcyla

      • 1.2.8 Adcertis

    • 1.3 Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Biotechnology Companies

      • 1.3.2 Specialized Cancer Centers

      • 1.3.3 Biopharmaceutical Companies

      • 1.3.4 Academic Research Institutes

      • 1.3.5 Hospitals

      • 1.3.6 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Antibody Drug Conjugate (ADC) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Antibody Drug Conjugate (ADC) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Antibody Drug Conjugate (ADC) Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Antibody Drug Conjugate (ADC) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Antibody Drug Conjugate (ADC) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Antibody Drug Conjugate (ADC) Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Antibody Drug Conjugate (ADC) Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Antibody Drug Conjugate (ADC) Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Antibody Drug Conjugate (ADC) Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Antibody Drug Conjugate (ADC) Drug Industry PEST Analysis

    • 2.3 Antibody Drug Conjugate (ADC) Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Antibody Drug Conjugate (ADC) Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Antibody Drug Conjugate (ADC) Drug Industry

    Chapter 3 Global and China Antibody Drug Conjugate (ADC) Drug Market, by Manufacturer

    • 3.1 Global and China Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Antibody Drug Conjugate (ADC) Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Antibody Drug Conjugate (ADC) Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Antibody Drug Conjugate (ADC) Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Antibody Drug Conjugate (ADC) Drug Market Top 3 Players

    Chapter 4 Global and China Antibody Drug Conjugate (ADC) Drug Market, by Type (2017-2028)

    • 4.1 Antibody Drug Conjugate (ADC) Drug Market Trend, by Type

    • 4.2 Global Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Antibody Drug Conjugate (ADC) Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Antibody Drug Conjugate (ADC) Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Antibody Drug Conjugate (ADC) Drug Price Trend, by Type (2017-2028)

    • 4.3 China Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Antibody Drug Conjugate (ADC) Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Antibody Drug Conjugate (ADC) Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Antibody Drug Conjugate (ADC) Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Antibody Drug Conjugate (ADC) Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Antibody Drug Conjugate (ADC) Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Antibody Drug Conjugate (ADC) Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Antibody Drug Conjugate (ADC) Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Antibody Drug Conjugate (ADC) Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Antibody Drug Conjugate (ADC) Drug Market Analysis

    • 7.1 North America Antibody Drug Conjugate (ADC) Drug Market, by Type

    • 7.2 North America Antibody Drug Conjugate (ADC) Drug Market, by Application

    • 7.3 North America Antibody Drug Conjugate (ADC) Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Antibody Drug Conjugate (ADC) Drug Market Analysis

    • 8.1 Europe Antibody Drug Conjugate (ADC) Drug Market, by Type

    • 8.2 Europe Antibody Drug Conjugate (ADC) Drug Market, by Application

    • 8.3 Europe Antibody Drug Conjugate (ADC) Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Antibody Drug Conjugate (ADC) Drug Market Analysis

    • 9.1 APAC Antibody Drug Conjugate (ADC) Drug Market, by Type

    • 9.2 APAC Antibody Drug Conjugate (ADC) Drug Market, by Application

    • 9.3 APAC Antibody Drug Conjugate (ADC) Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Antibody Drug Conjugate (ADC) Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Antibody Drug Conjugate (ADC) Drug Company Profiles

      • 11.1 Oxford Bio Therapeutics

        • 11.1.1 Oxford Bio Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sanofi

        • 11.2.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sanofi Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.2.3 Sanofi Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Millennium Pharmaceuticals

        • 11.3.1 Millennium Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.3.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Genentech

        • 11.4.1 Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Genentech Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.4.3 Genentech Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Amgen

        • 11.5.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Amgen Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.5.3 Amgen Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Celldex Therapeutics

        • 11.6.1 Celldex Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.6.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Immunomedics

        • 11.7.1 Immunomedics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Immunomedics Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.7.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Bayer HealthCare

        • 11.8.1 Bayer HealthCare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.8.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Mersana Therapeutics

        • 11.9.1 Mersana Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.9.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 ImmunoGen

        • 11.10.1 ImmunoGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 ImmunoGen Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.10.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Concortis Bio therapeutics

        • 11.11.1 Concortis Bio therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.11.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Heidelberg Pharma

        • 11.12.1 Heidelberg Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.12.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Seattle Genetics

        • 11.13.1 Seattle Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.13.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 AbbVie Inc

        • 11.14.1 AbbVie Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.14.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Synthon

        • 11.15.1 Synthon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Synthon Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.15.3 Synthon Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Genmab

        • 11.16.1 Genmab Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Genmab Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.16.3 Genmab Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Novartis

        • 11.17.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Novartis Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.17.3 Novartis Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Agensys

        • 11.18.1 Agensys Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Agensys Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.18.3 Agensys Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Pfizer

        • 11.19.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Pfizer Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.19.3 Pfizer Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Progenics Pharmaceuticals

        • 11.20.1 Progenics Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.20.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Roche Holding AG

        • 11.21.1 Roche Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.21.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Eli Lilly

        • 11.22.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Eli Lilly Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.22.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.23 Astellas Pharma/Agensys

        • 11.23.1 Astellas Pharma/Agensys Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.23.2 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product Profiles, Application and Specification

        • 11.23.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Antibody Drug Conjugate (ADC) Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Antibody Drug Conjugate (ADC) Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Antibody Drug Conjugate (ADC) Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Production Value and Growth Rate (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of by Technology (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Mmunomedics Technology (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Immunogen Technology (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Mersana Therapeutics Technology (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of by Product Type (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Kadcyla (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Adcertis (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Biotechnology Companies (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Specialized Cancer Centers (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Biopharmaceutical Companies (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Academic Research Institutes (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Antibody Drug Conjugate (ADC) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Antibody Drug Conjugate (ADC) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Antibody Drug Conjugate (ADC) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Antibody Drug Conjugate (ADC) Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Antibody Drug Conjugate (ADC) Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Antibody Drug Conjugate (ADC) Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Antibody Drug Conjugate (ADC) Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Antibody Drug Conjugate (ADC) Drug Market Share, by Manufacturer in 2022

    • Table Global Antibody Drug Conjugate (ADC) Drug Sales Volume, by Type (2017-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Sales Value, by Type (2017-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Price Trend, by Type (2017-2028)

    • Table China Antibody Drug Conjugate (ADC) Drug Sales Volume, by Type (2017-2028)

    • Table China Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Table China Antibody Drug Conjugate (ADC) Drug Sales Value, by Type (2017-2028)

    • Table China Antibody Drug Conjugate (ADC) Drug Sales Value Share, by Type (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Price Trend, by Type (2017-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Sales Volume, by Application (2017-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Sales Value, by Application (2017-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Sales Value Share, by Application (2017-2028)

    • Table China Antibody Drug Conjugate (ADC) Drug Sales Volume, by Application (2017-2028)

    • Table China Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Table China Antibody Drug Conjugate (ADC) Drug Sales Value, by Application (2017-2028)

    • Table China Antibody Drug Conjugate (ADC) Drug Sales Value Share, by Application (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Sales Value Share, by Application (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Antibody Drug Conjugate (ADC) Drug Sales Volume, by Type (2017-2028)

    • Table North America Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Antibody Drug Conjugate (ADC) Drug Sales Volume, by Application (2017-2028)

    • Table North America Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Antibody Drug Conjugate (ADC) Drug Sales Volume, by Type (2017-2028)

    • Table Europe Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Antibody Drug Conjugate (ADC) Drug Sales Volume, by Application (2017-2028)

    • Table Europe Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Antibody Drug Conjugate (ADC) Drug Sales Volume, by Type (2017-2028)

    • Table APAC Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Antibody Drug Conjugate (ADC) Drug Sales Volume, by Application (2017-2028)

    • Table APAC Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Antibody Drug Conjugate (ADC) Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Antibody Drug Conjugate (ADC) Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Antibody Drug Conjugate (ADC) Drug Sales Value and Growth Rate (2017-2028)

    • Table Oxford Bio Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Oxford Bio Therapeutics Product Profiles, Application and Specification

    • Table Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Millennium Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Millennium Pharmaceuticals Product Profiles, Application and Specification

    • Table Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genentech Product Profiles, Application and Specification

    • Table Genentech Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celldex Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celldex Therapeutics Product Profiles, Application and Specification

    • Table Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Immunomedics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Immunomedics Product Profiles, Application and Specification

    • Table Immunomedics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer HealthCare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer HealthCare Product Profiles, Application and Specification

    • Table Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mersana Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mersana Therapeutics Product Profiles, Application and Specification

    • Table Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ImmunoGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ImmunoGen Product Profiles, Application and Specification

    • Table ImmunoGen Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Concortis Bio therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Concortis Bio therapeutics Product Profiles, Application and Specification

    • Table Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Heidelberg Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Heidelberg Pharma Product Profiles, Application and Specification

    • Table Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Seattle Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Seattle Genetics Product Profiles, Application and Specification

    • Table Seattle Genetics Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Inc Product Profiles, Application and Specification

    • Table AbbVie Inc Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synthon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synthon Product Profiles, Application and Specification

    • Table Synthon Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genmab Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genmab Product Profiles, Application and Specification

    • Table Genmab Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agensys Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agensys Product Profiles, Application and Specification

    • Table Agensys Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Progenics Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Progenics Pharmaceuticals Product Profiles, Application and Specification

    • Table Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Holding AG Product Profiles, Application and Specification

    • Table Roche Holding AG Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma/Agensys Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma/Agensys Product Profiles, Application and Specification

    • Table Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US